Home Tools
Log in
Cart

Search Result

Search Results for " p-met "

16

Compounds

Cat No. Product Name Synonyms Targets
TP1369L [Sar9,Met(O2)11]-Substance P acetate [Sar9,Met(O2)11]-Substance P acetate(110880-55-2 free base) Neurokinin receptor
[Sar9,Met(O2)11]-Substance P acetate is a tachykinin NK1 receptor selective agonist. [Sar9,Met(O2)11]-Substance P acetate is a selective tachykinin NK1 receptor agonist.[Sar9,Met(O2)11]-Substance P acetate and septide (1...
T7828 [Sar9,Met(O2)11]-Substance P Bhsar-sp,NA Neurokinin receptor
[Sar9,Met(O2)11]-Substance P (NA) is an agonist of NK1 receptor.
TP1369 [Sar9,Met(O2)11]-Substance P TFA(110880-55-2,free) [Sar9,Met(O2)11]-Substance P TFA
[Sar9,Met(O2)11]-Substance P TFA is a selective tachykinin NK1 receptor agonist.[Sar9,Met(O2)11]-Substance P and septide (10-100 pmol per rat, i.c.v.) are equipotent in increasing mean arterial blood pressure (MAP) and h...
T9052 XL092 CL-092,JUN04542 VEGFR , c-Met/HGFR , TAM Receptor
XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders.
T75769 [Sar9,Met(O2)11]-Substance P TFA
[Sar9,Met(O2)11]-Substance P TFA is a tachykinin NK 1 receptor selective agonist.
T25098 Antiflammin P2 Hdmnkvldl,Antiflamin 2,His-asp-met-asn-lys-val-leu-asp-leu
Antiflammin P2 is a nonapeptide fragment of lipocortin I which has no phospholipase A2 inhibitory and anti-inflammatory activity.
TQ0210 Savolitinib AZD-6094,Volitinib,HMPL-504 c-Met/HGFR
Savolitinib (Volitinib) (AZD-6094) is an effective, selective, and orally bioavailable c-Met inhibitor (IC50s: 5 nM/3 nM for c-Met/p-Met).
T77575 P-gb-IN-1 P-gp
P-gb-IN-1 is a potent P-glycoprotein (P-gp) inhibitor that exhibits reverse activity by inhibiting P-gp outflow. P-gb-IN-1 has been shown to inhibit P-gp by hydrogen bonding with residues Asn 721 and Met 986. P-gb-IN-1 s...
TP1862L [Sar9] Substance P acetate(77128-75-7 free base) Neurokinin receptor
[Sar9]-Substance P acetate is one of NK-1 receptor agonist. The action of SP on progesterone metabolism was mimicked by the rNK1-specific agonist [Sar-9,Met(O2)11]-SP.
T76452 Gly-Leu-Met-NH2
Gly-Leu-Met-NH2 is a C-terminal tripeptide of Substance P ( Substance P ). Substance P is a neuropeptide [1] .
T15384 Glesatinib MGCD265 c-Met/HGFR
Glesatinib is an orally active and potent dual inhibitor of MET/SMO. Glesatinib is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC.
T76449 Substance P (alligator)
Substance P (alligator), a neuropeptide derived from alligator, possesses a primary structure delineated as Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 [1].
T15383 Glesatinib hydrochloride MGCD265 hydrochloride c-Met/HGFR
Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET/SMO. Glesatinib hydrochloride is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC.
T70456 Nolpitantium Free Base
Nolpitantium Free Base is a highly selective nonpeptide antagonist of neurokinin-1 (NK1) receptor. Nolpitantium potently, selectively and competitively inhibited substance P binding to NK1 receptors from various animal s...
TP1862 [Sar9] Substance P
[Sar9]-Substance P is one of NK-1 receptor agonist. The action of SP on progesterone metabolism was mimicked by the rNK1-specific agonist [Sar-9,Met(O2)11]-SP.
T29186 YM49598 YM-49598,YM 49598
YM49598 is a tachykinin receptor antagonist. YM49598 exhibited high binding affinities at NK(1) (pK(i) = 9.09 +/- 0.02) and NK(2) (pK(i) = 9.94 +/- 0.03) receptors, respectively. YM49598 was almost inactive but produced ...
TargetMol